# Machine Learning and Bioinformatics Framework for Breast Cancer Subtype Classification and Biomarker Discovery

ðŸ“Œ Overview

This project presents an integrative approach combining **bioinformatics analysis** and **machine learning models** to identify reliable biomarkers and classify molecular subtypes of **breast cancer** (BRCA) using **microarray gene expression data** from GEO datasets.
By leveraging tools such as differential expression analysis, protein-protein interaction networks, survival analysis, and supervised machine learning (Random Forest & KNN), the study uncovers 2 potential subtype-specific robust biomarkers and evaluates their diagnostic and prognostic significance.

ðŸ”¬ Objectives

Identify DEGs linked to breast cancer subtypes using GEO microarray data, then construct PPI networks and identify key hub genes.
Perform subtype-specific DEG analysis to find unique molecular signatures, followed by developing ML models for subtype classification and biomarker prioritization.

ðŸ§ª Datasets Used

**GSE86374** (10 normal, 50 tumor samples)
**GSE57297** (7 normal, 25 tumor samples)  
 (Retrieved from the Gene Expression Omnibus (GEO))

ðŸ§° Technologies and Tools

 **Languages**: Python, R  
 **Libraries**: `scikit-learn`, `matplotlib`, `pandas`, `seaborn`, `Limma` (R)  
 **Databases**: GEO, STRING, Enrichr, TNMplot, GEPIA2, cBioPortal 
 **Software**: Cytoscape, Google Colab

ðŸ§¬ Bioinformatic Analysis

 **72 common DEGs** identified between datasets
 **10 hub genes** highlighted from the PPI network (e.g., KIT, TPM3, MYLK, COL10A1)
 **Survival analysis** confirmed clinical significance of multiple genes.
  
ðŸ§  Machine Learning Models 

|    Model      | Accuracy | F1 Score | AUC-OVR | 
|---------------|----------|----------|---------|
| Random Forest |   ~79%   |   ~77%   |   ~91%  |
| KNN           |   ~88%   |   ~87%   |   ~92%  | 

- **KNN** showed superior performance on microarray data.
- Feature importance was used to prioritize candidate biomarker genes.

**5276 subtype specific DEGs** involved in ML modeling
 **2 candidate biomarkers** prioritized via ML, including:  
  'PNMT', 'KRTAP10-8'


